Newsletter Archive
‘I’m not gonna give up’: New Alzheimer’s treatments offer optimism
 | ‘I’m not gonna give up’: New Alzheimer’s treatments offer optimism June is Alzheimer’s & Brain Awareness Month and doctors at the Cleveland Clinic are optimistic about new treatments and clinical trials for patients. fox8.com |
Can a FDA Approved Memory Loss Drug Already on the Market Prevent Alzheimer’s Disease? Study in the Works at CWRU, Dr. Alan Lerner
View news video here
Raising Awareness About AD
Read the full story in The Daily here
Case Western Reserve University Researcher of the CADRC Helps to Expand Alzheimer’s Disease Research with Cleveland’s African American Communities
Read full story here
Grant Awarded to
Dr. Jagan Pillai
New 5-Year National Institute of Aging (NIA) Research Grant Awarded to Dr. Jagan Pillai to Evaluate Immune Cell Activation and Blood Brain Barrier Changes at Different Stages of Alzheimer’s Disease
Click here for more information
Grant Awarded to
Dr. Stephen Rao
& Dr. Jay Alberts
U.S. National Institute of Health (NIH) Awards 5-Year Grant to Dr. Stephen Rao and Dr. Jay Alberts to Study the Impact of a Home Based, High Intensity Exercise Program for Those Who Have a Genetic Risk for Alzheimer’s Disease (AD)
Click here for more information
Grant Awarded to
Dr. Wenzhang Wang
National Institute on
Aging Awards
$2 Million to Dr. Wenzhang Wang to Study ApoE and Abeta Which is Believed to Be a Key Cause of Alzheimer’s Disease
Click here for more information
National Institute on Aging Awards
$15.4 Million to Continue Support for
Cleveland Alzheimer’s Disease Research Center
August 24, 2021, CLEVELAND: The National Institute on Aging of the National Institutes of Health (NIH) has awarded a grant expected to total $15.4million to continue funding the Cleveland Alzheimer’s Disease Research Center. The new five-year award will support the multi-institution collaborative, which aims to accelerate research for Alzheimer’s disease and related dementias.
Click here for more information
CADRC Investigator News
Lynn Bekris, PhD, Associate Staff at the Cleveland Clinic Genomic Medicine Institute and leader of the CADRC Biomarker Core, has been awarded a three-year, nearly $300,000 grant from the Aging Mind Foundation to study inflammatory factors involved in the early stages of Alzheimer’s disease (AD) in order to better understand the underlying cause of AD and inform novel therapeutic strategies.
“There is a growing body of evidence in the field that Alzheimer’s disease develops much earlier than previously thought, most likely decades before our current ability to clinically diagnose the condition,” said study co-author Andrew A. Pieper.NEW ALZHEIMER’S DISEASE PATHWAY DISCOVERED, PROVIDING EARLIER TARGET FOR POTENTIAL THERAPIES – THE DAILY
OREC Team Member
“Our goal is to provide supportive intervention for those caring for someone with dementia, particularly during these transitional periods of caregiving for persons with dementia,” Zauszniewski said.NURSING’S JACLENE ZAUSZNIEWSKI AWARDED $2.6M GRANT TO STUDY STRESS MANAGEMENT IN CAREGIVERS OF PEOPLE WITH DEMENTIA – THE DAILY